Actively Recruiting
A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter
Led by LeMaitre Vascular · Updated on 2024-10-18
112
Participants Needed
3
Research Sites
281 weeks
Total Duration
On this page
Sponsors
L
LeMaitre Vascular
Lead Sponsor
A
Avania
Collaborating Sponsor
AI-Summary
What this Trial Is About
A post market clinical study to confirm the performance and safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter on patients undergoing surgical treatment for the removal of arterial emboli and/or thrombi
CONDITIONS
Official Title
A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 years or older
- Scheduled for surgical removal of arterial or venous emboli and/or thrombi using a LeMaitre4 Embolectomy Catheter
- Signed informed consent to participate
- Diagnosed with an embolus or thrombus
- Thrombolytic therapy has failed or is contraindicated
You will not qualify if you...
- Presence of co-morbidities that could affect study results as judged by the investigator
- Unable to read or write
- Pregnant or breastfeeding at enrollment
- Immune compromised
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Ziekenhuis Oost-Limburg
Genk, Belgium
Actively Recruiting
2
Andrej Udelnow
Brandenburg, Germany
Actively Recruiting
3
Giorgio Prouse
Lugano, Switzerland
Not Yet Recruiting
Research Team
A
Andrew Hodgkinson
CONTACT
B
Brian Orrick
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here